Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium
Top Cited Papers
- 29 November 2005
- journal article
- Published by Elsevier in The Lancet Oncology
- Vol. 7 (1) , 27-38
- https://doi.org/10.1016/s1470-2045(05)70434-4
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Cigarette Smoking and Risk of Non-Hodgkin Lymphoma: A Pooled Analysis from the International Lymphoma Epidemiology Consortium (InterLymph)Cancer Epidemiology, Biomarkers & Prevention, 2005
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphomaBlood, 2004
- Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphomaLeukemia, 2004
- Signalling pathways of the TNF superfamily: a double-edged swordNature Reviews Immunology, 2003
- In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loadingNature Genetics, 2003
- Cytokines and their role in lymphoid development, differentiation and homeostasisCurrent Opinion in Allergy and Clinical Immunology, 2002
- Score Tests for Association between Traits and Haplotypes when Linkage Phase Is AmbiguousAmerican Journal of Human Genetics, 2002
- The rise in incidence of lymphomas in Europe 1985–1992European Journal Of Cancer, 1999
- Genetic influence on cytokine production in meningococcal diseaseThe Lancet, 1997